Myotubular myopathy is a severe genetic disease that leads to muscle paralysis. Although no treatment currently exists, researchers have identified a molecule that not only greatly reduces the progression of the disease but also boosts life expectancy in animal models by a factor of seven. Since the molecule — known as tamoxifen — is already used for breast cancer, the researchers hope to soon set up a clinical trial.
This post was syndicated from Top Health News -- ScienceDaily. Click here to read the full text on the original website.